Sibylle Mellinghoff

30PUBLICATIONS
129CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunologyEnvironmental epidemiologyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|May 12, 2026
Clinical impact of potential drug-drug interactions between midostaurin and posaconazole in FLT3-mutated AML.

|Feb 11, 2026
Beyond Antibodies: Influenza Vaccine Induced T-Cell Response in Hematological Malignancy- Commentary on Insights From Hall et al.

Katja M Sauer, Eloísa Felipe Fumero, Oliver A Cornely

|Jul 09, 2025
[Respiratory syncytial virus-not only relevant for hygienic reasons].

Enrico Schalk, Christina T Rieger, Oliver A Cornely

|May 26, 2025
Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC): Protocol for Multicenter Prospective Noninterventional Study.

Louise Marie Cremer, Ullrich Bethe, Peter Borchmann

|Mar 28, 2025
Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024.

Louise M Cremer, Jannik Stemler, Rosanne Sprute

|Mar 17, 2025
Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment Option.

Sibylle C Mellinghoff, Martin Thelen, Michael von Bergwelt-Baildon

Pageof 5

Frequent Collaborators

26 joint publications

Oliver A Cornely

13 joint publications

Jannik Stemler

10 joint publications

Jon Salmanton-García

7 joint publications

Philipp Köhler